Amarin Corp Plc (AMRN)

[biowreck]

Writing for Jefferies at the end of February Michael Yee said, "We continue to think Vascepa checks many boxes as a wholly owned potential blockbuster that would do even better in the hands of big pharma global distribution." He sees a 71% potential to the stock, and gives it a $30 price target.

Hoping for a better buyout price...but i gotra go with Yee over ye ol saltdog JL lol!